Most side effects were mild to moderate and transient. Fever was very rare. The most common side effects in the vaccine recipients included pain and tenderness at the injection site, headache, muscle aches and fatigue that lasted a day on average. None of the recipients developed serious reactions like heart inflammation (myocarditis) or blood clots.
Meanwhile, a total of 110 countries have recognised India's vaccines, Covishield and Covaxin, and agreed to the mutual recognition of Covid-19 vaccination certificates with India.
Biotechnology firm Novavax Inc and its partner Serum Institute of India on Monday said they have received the first emergency use authorisation (EUA) for Novavax's COVID-19 vaccine, in Indonesia.
Copyright © 2024 - Odisha Television Limited All Rights Reserved.